NMR line-broadening and transferred NOESY as a medicinal chemistry tool for studying inhibitors of the hepatitis C virus NS3 protease domain

被引:37
作者
LaPlante, SR
Aubry, N
Bonneau, PR
Kukolj, G
Lamarre, D
Lefebvre, S
Li, H
Llinàs-Brunet, M
Plouffe, C
Cameron, DR
机构
[1] Boehringer Ingelheim Canada Ltd, Dept Chem, Laval, PQ H7S 2G5, Canada
[2] Boehringer Ingelheim Canada Ltd, Dept Biol Sci, Laval, PQ H7S 2G5, Canada
关键词
D O I
10.1016/S0960-894X(00)00466-2
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
This work describes the use of NMR as a medicinal chemistry tool for better understanding the binding characteristics of inhibitors of the HCV NS3 protease. The protease-bound structure of a tetrapeptide-like inhibitor that has an acid C-terminus, a norvaline at P1 and a naphthylmethoxy proline at P2 is described. Conformational comparisons are made with a similar compound having a 1-amino-cyclopropylcarboxylic acid at P1 and with a hexapeptide inhibitor. Differences between the free and bound states are identified. F-19 NMR also helped in determining that a single complex is observed when an inhibitor is added to the protease at a 1:1 ratio. (C) 2000 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:2271 / 2274
页数:4
相关论文
共 13 条
[1]   The solution structure of the N-terminal proteinase domain of the hepatitis C virus (HCV) NS3 protein provides new insights into its activation and catalytic mechanism [J].
Barbato, G ;
Cicero, DO ;
Nardi, MC ;
Steinkühler, C ;
Cortese, R ;
De Francesco, R ;
Bazzo, R .
JOURNAL OF MOLECULAR BIOLOGY, 1999, 289 (02) :371-384
[2]   NONSTRUCTURAL PROTEIN-3 OF THE HEPATITIS-C VIRUS ENCODES A SERINE-TYPE PROTEINASE REQUIRED FOR CLEAVAGE AT THE NS3/4 AND NS4/5 JUNCTIONS [J].
BARTENSCHLAGER, R ;
AHLBORNLAAKE, L ;
MOUS, J ;
JACOBSEN, H .
JOURNAL OF VIROLOGY, 1993, 67 (07) :3835-3844
[3]   Molecular targets in inhibition of hepatitis C virus replication [J].
Bartenschlager, R .
ANTIVIRAL CHEMISTRY & CHEMOTHERAPY, 1997, 8 (04) :281-301
[4]   The treatment of chronic viral hepatitis [J].
Hoofnagle, JH ;
DiBisceglie, AM .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (05) :347-356
[5]   Hepatitis C virus-encoded enzymatic activities and conserved RNA elements in the 3′ nontranslated region are essential for virus replication in vivo [J].
Kolykhalov, AA ;
Mihalik, K ;
Feinstone, SM ;
Rice, CM .
JOURNAL OF VIROLOGY, 2000, 74 (04) :2046-2051
[6]   Solution structure of substrate-based ligands when bound to hepatitis C virus NS3 protease domain [J].
LaPlante, SR ;
Cameron, DR ;
Aubry, N ;
Lefebvre, S ;
Kukolj, G ;
Maurice, R ;
Thibeault, D ;
Lamarre, D ;
Llinàs-Brunet, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (26) :18618-18624
[7]   Highly potent and selective peptide-based inhibitors of the hepatitis C virus serine protease:: Towards smaller inhibitors [J].
Llinàs-Brunet, M ;
Bailey, M ;
Fazal, G ;
Ghiro, E ;
Gorys, V ;
Goulet, S ;
Halmos, T ;
Maurice, R ;
Poirier, M ;
Poupart, MA ;
Rancourt, J ;
Thibeault, D ;
Wernic, D ;
Lamarre, D .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2000, 10 (20) :2267-2270
[8]   Peptide-based inhibitors of the hepatitis C virus serine protease [J].
Llinàs-Brunet, M ;
Bailey, M ;
Fazal, G ;
Goulet, S ;
Halmos, T ;
Laplante, S ;
Maurice, R ;
Poirier, M ;
Poupart, MA ;
Thibeault, D ;
Wernic, D ;
Lamarre, D .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1998, 8 (13) :1713-1718
[9]  
Marchetti A, 1999, SYNLETT, P1000
[10]  
NI F, 1994, PROG NUCL MAG RES SP, V26, P517, DOI 10.1016/0079-6565(94)90000-0